Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen-Targeted PET Imaging: PSMA-RADS Version 1.0.
作者信息
Rowe Steven P, Pienta Kenneth J, Pomper Martin G, Gorin Michael A
机构信息
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
出版信息
J Nucl Med. 2018 Mar;59(3):479-485. doi: 10.2967/jnumed.117.195255. Epub 2017 Sep 8.
Abstract
摘要
相似文献
1
Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen-Targeted PET Imaging: PSMA-RADS Version 1.0.前列腺特异性膜抗原靶向PET成像结构化报告系统提案：PSMA-RADS 1.0版
J Nucl Med. 2018 Mar;59(3):479-485. doi: 10.2967/jnumed.117.195255. Epub 2017 Sep 8.
2
Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories.前列腺癌患者 PSMA 靶向 PET 放射性示踪剂摄取可疑病灶的随访：PSMA-RADS-3A 和 PSMA-RADS-3B 类别的预测值。
J Nucl Med. 2019 Apr;60(4):511-516. doi: 10.2967/jnumed.118.217653. Epub 2018 Sep 6.
3
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on F-DCFPyL PET/CT Imaging.PSMA-RADS 1.0 标准化报告系统在 F-DCFPyL PET/CT 成像中的观察者间一致性。
J Nucl Med. 2018 Dec;59(12):1857-1864. doi: 10.2967/jnumed.118.217588. Epub 2018 Sep 6.
4
Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls.前列腺特异性膜抗原（PSMA）靶向 PET 成像在前列腺癌中的应用：重要陷阱的最新研究进展。
Semin Nucl Med. 2019 Jul;49(4):255-270. doi: 10.1053/j.semnuclmed.2019.02.006. Epub 2019 Mar 4.
5
68Ga-Prostate-Specific Membrane Antigen-Avid Tubercular Lesions Mimicking Prostate Cancer Metastasis on Simultaneous Prostate-Specific Membrane Antigen PET/MRI.68Ga-前列腺特异性膜抗原摄取的结核病灶在前列腺特异性膜抗原 PET/MRI 上模拟前列腺癌转移。
Clin Nucl Med. 2017 Dec;42(12):e509-e510. doi: 10.1097/RLU.0000000000001874.
6
Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer.前列腺特异性膜抗原PET成像在前列腺癌中的当前应用及未来展望
Q J Nucl Med Mol Imaging. 2019 Mar;63(1):7-18. doi: 10.23736/S1824-4785.18.03059-5. Epub 2018 Mar 8.
7
Prostate-specific Membrane Antigen Reporting and Data System Version 2.0.前列腺特异性膜抗原报告和数据系统第 2.0 版。
Eur Urol. 2023 Nov;84(5):491-502. doi: 10.1016/j.eururo.2023.06.008. Epub 2023 Jul 4.
8
Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications.分子影像报告与数据系统（MI-RADS）：具有治疗诊断意义的靶向放射性示踪剂的通用框架。
Ann Nucl Med. 2018 Oct;32(8):512-522. doi: 10.1007/s12149-018-1291-7. Epub 2018 Aug 14.
9
Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer.用于前列腺癌正电子发射断层显像（PET）的新型靶向前列腺特异性膜抗原的18F标记探针的合成与生物学评价
J Nucl Med. 2016 Dec;57(12):1978-1984. doi: 10.2967/jnumed.116.175810. Epub 2016 Jul 14.
10
Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer.前列腺特异性膜抗原（PSMA）配体用于前列腺癌的诊断和治疗。
Expert Rev Mol Diagn. 2016 Nov;16(11):1177-1188. doi: 10.1080/14737159.2016.1243057. Epub 2016 Oct 14.
引用本文的文献
1
Interobserver and intraobserver agreement for equivocal lesions in Ga-68 PSMA PET/CT according to PSMA-RADS 2.0 criteria.根据PSMA-RADS 2.0标准，68Ga-PSMA PET/CT中可疑病变的观察者间和观察者内一致性。
Ann Nucl Med. 2025 Sep 10. doi: 10.1007/s12149-025-02103-x.
2
An Innovative Approach with [Ga]Ga-PSMA PET/CT: The Relationship Between PRIMARY Scores and Clinical and Histopathological Findings.一种采用[镓]镓-PSMA PET/CT的创新方法：PRIMARY评分与临床及组织病理学发现之间的关系。
Diagnostics (Basel). 2025 Jul 15;15(14):1779. doi: 10.3390/diagnostics15141779.
3
Assessing the frequency and accuracy of morphologic changes of focal bone lesions on [Ga]Ga-PSMA-11 PET/CT in prostate cancer.评估[镓]Ga-PSMA-11 PET/CT对前列腺癌局灶性骨病变形态学变化的频率和准确性。
Eur J Nucl Med Mol Imaging. 2025 Jun 17. doi: 10.1007/s00259-025-07331-x.
4
Comparison of mpMRI and Ga-PSMA-PET/CT in the Assessment of the Primary Tumors in Predominant Low-/Intermediate-Risk Prostate Cancer.多参数磁共振成像（mpMRI）与镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描（Ga-PSMA-PET/CT）在评估主要为低/中危前列腺癌原发肿瘤中的比较
Diagnostics (Basel). 2025 May 28;15(11):1358. doi: 10.3390/diagnostics15111358.
5
Biphasic contrast-enhanced [F]PSMA-1007 PET/CT imaging to improve the detection of local relapse of prostate cancer.双相对比增强[F]PSMA - 1007 PET/CT成像以提高前列腺癌局部复发的检测率
EJNMMI Res. 2025 May 30;15(1):61. doi: 10.1186/s13550-025-01252-4.
6
Comparison of Prostate-specific Membrane Antigen Reporting and Data System Version 1.0 versus 2.0 for Prostate Cancer Assessment.用于前列腺癌评估的前列腺特异性膜抗原报告与数据系统1.0版和2.0版的比较
Radiol Imaging Cancer. 2025 May;7(3):e240390. doi: 10.1148/rycan.240390.
7
PSMA PET/CT scan reveals incidental meningioma in a prostate cancer patient.前列腺特异性膜抗原（PSMA）正电子发射断层扫描/计算机断层扫描（PET/CT）显示一名前列腺癌患者意外发现脑膜瘤。
Urol Case Rep. 2025 Mar 24;60:103022. doi: 10.1016/j.eucr.2025.103022. eCollection 2025 May.
8
The Evaluation of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Initial Staging in Intermediate-Risk Prostate Cancer Patients: A Retrospective Multicenter Analysis.放射性标记前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描用于中危前列腺癌患者初始分期的评估：一项回顾性多中心分析
Diagnostics (Basel). 2024 Dec 6;14(23):2751. doi: 10.3390/diagnostics14232751.
9
Focal Unspecific Bone Uptake on [F]PSMA-1007 PET: Evaluation Analog PROMISE Criteria and Validation via PET/CT Follow-Up.[F]PSMA - 1007 PET上的局灶性非特异性骨摄取：类比PROMISE标准评估及PET/CT随访验证
Diagnostics (Basel). 2024 Oct 18;14(20):2327. doi: 10.3390/diagnostics14202327.
10
PSMA PET/CT imaging and its application to prostate cancer treatment.前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描成像及其在前列腺癌治疗中的应用。
Jpn J Radiol. 2025 Jan;43(1):1-12. doi: 10.1007/s11604-024-01646-9. Epub 2024 Sep 3.
本文引用的文献
1
ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee.美国放射学会甲状腺影像报告和数据系统（TI-RADS）：美国放射学会TI-RADS委员会白皮书
J Am Coll Radiol. 2017 May;14(5):587-595. doi: 10.1016/j.jacr.2017.01.046. Epub 2017 Apr 2.
2
Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.镓-前列腺特异性膜抗原正电子发射断层显像/计算机断层扫描：欧洲核医学协会和美国核医学与分子影像学会联合发布的前列腺癌成像程序指南：第1.0版
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024. doi: 10.1007/s00259-017-3670-z.
3
Molecular Imaging in Neuroendocrine Differentiation of Prostate Cancer: 68Ga-PSMA Versus 68Ga-DOTA NOC PET-CT.前列腺癌神经内分泌分化的分子影像学：68Ga-PSMA 与 68Ga-DOTA-NOC PET-CT 比较。
Clin Nucl Med. 2017 May;42(5):410-413. doi: 10.1097/RLU.0000000000001618.
4
Incidental Detection of Head and Neck Squamous Cell Carcinoma on 68Ga-PSMA-11 PET/CT.68Ga-PSMA-11 PET/CT 偶然检测到头颈部鳞状细胞癌。
Clin Nucl Med. 2017 Apr;42(4):e218-e220. doi: 10.1097/RLU.0000000000001569.
5
PSMA Uptake in Mediastinal Sarcoidosis.纵隔结节病中的 PSMA 摄取。
Clin Nucl Med. 2017 Apr;42(4):303-305. doi: 10.1097/RLU.0000000000001543.
6
Prostate-Specific Membrane Antigen PET/CT: Uptake in Lymph Nodes With Active Sarcoidosis.前列腺特异性膜抗原 PET/CT：活性结节病淋巴结摄取。
Clin Nucl Med. 2017 Mar;42(3):e175-e176. doi: 10.1097/RLU.0000000000001528.
7
Incidental Detection of Thyroid Metastases From Renal Cell Carcinoma Using 68Ga-PSMA PET/CT to Assess Prostate Cancer Recurrence.使用 68Ga-PSMA PET/CT 偶然检测肾细胞癌转移的甲状腺癌以评估前列腺癌复发。
Clin Nucl Med. 2017 Mar;42(3):221-222. doi: 10.1097/RLU.0000000000001522.
8
Semiquantitative Parameters in PSMA-Targeted PET Imaging with F-DCFPyL: Variability in Normal-Organ Uptake.使用F-DCFPyL进行PSMA靶向PET成像的半定量参数：正常器官摄取的变异性
J Nucl Med. 2017 Jun;58(6):942-946. doi: 10.2967/jnumed.116.179739. Epub 2016 Dec 8.
9
Incidental Meningioma Mimicking Metastasis of Prostate Adenocarcinoma in 68Ga-Labeled PSMA Ligand PET/CT.前列腺腺癌转移的 68Ga-PSMA 配体 PET/CT 中偶然脑膜瘤的模拟
Clin Nucl Med. 2016 Dec;41(12):956-958. doi: 10.1097/RLU.0000000000001406.
10
Serous Cystadenoma of the Pancreas Showing Uptake on 68Ga PSMA PET/CT.胰腺浆液性囊腺瘤在 68Ga PSMA PET/CT 上摄取。
Clin Nucl Med. 2017 Jan;42(1):56-57. doi: 10.1097/RLU.0000000000001423.
Zotero 插件